ArticleBMC urology2022
CALN1 hypomethylation as a biomarker for high-risk bladder cancer.
Kimiaki Takagi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleBMC urology2022
Kimiaki Takagi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.